Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2019.
The company has reported 66.91% rise in its net profit at Rs 231.19 crore for the quarter under review as compared to Rs 138.51 crore for the same quarter in the previous year. Total income of the company increased by 15.92% at Rs 1,052.65 crore for Q3FY20 as compared Rs 908.08 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 37.90% in its net profit at Rs 234.19 crore for the quarter under review as compared to Rs 169.83 crore for the same quarter in the previous year. Total income of the company increased by 18.39% at Rs 1,209.54 crore for Q3FY20 as compared Rs 1,021.67 crore for the corresponding quarter previous year.
